Sai Life Sciences opens discovery biology facility in Hyderabad

Sai Life Sciences, full-service contract research, development and manufacturing organisation (CRO-CDMO), has announced the opening of a new biology facility at its integrated R&D campus in Hyderabad. The new state-of-the-art facility houses expanded in vitro and in vivo biology services, DMPK, toxicology and a vivarium. The facility augments both, its capabilities and capacity, to deploy cutting-edge platforms and technologies for accelerating integrated drug discovery programmes. The new facility culminates the company’s journey of unifying its discovery, early and late phase development and clinical supply capabilities in a single 13-acre campus housing over 1000 scientists, delivering integrated value at scale. The company’s discovery services support a wide range of global innovator companies from startups to large pharma companies, across a diverse set of therapeutic areas including oncology, CNS, antivirals, and inflammation among others.